loading
전일 마감가:
$2.60
열려 있는:
$2.61
하루 거래량:
35,819
Relative Volume:
0.03
시가총액:
$347.09M
수익:
-
순이익/손실:
$-45.44M
주가수익비율:
-7.3714
EPS:
-0.35
순현금흐름:
$-42.28M
1주 성능:
+6.88%
1개월 성능:
+21.56%
6개월 성능:
+75.68%
1년 성능:
+113.75%
1일 변동 폭
Value
$2.54
$2.61
1주일 범위
Value
$2.32
$2.76
52주 변동 폭
Value
$0.765
$4.08

Compass Therapeutics Inc Stock (CMPX) Company Profile

Name
명칭
Compass Therapeutics Inc
Name
전화
617-500-8099
Name
주소
80 GUEST STREET, BOSTON
Name
직원
35
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
CMPX's Discussions on Twitter

CMPX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
CMPX
Compass Therapeutics Inc
2.58 347.09M 0 -45.44M -42.28M -0.35
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
444.71 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
527.92 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
317.57 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
562.85 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
243.34 28.51B 3.81B -644.79M -669.77M -6.24

Compass Therapeutics Inc Stock (CMPX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-04-02 업그레이드 Leerink Partners Market Perform → Outperform
2025-02-24 개시 Guggenheim Buy
2025-02-19 개시 Piper Sandler Overweight
2024-12-23 개시 D. Boral Capital Buy
2024-11-15 다운그레이드 Leerink Partners Outperform → Market Perform
2024-09-16 업그레이드 Ladenburg Thalmann Neutral → Buy
2023-01-31 개시 Jefferies Buy
2023-01-27 개시 Stifel Buy
2022-05-23 재개 H.C. Wainwright Buy
2022-03-15 개시 Ladenburg Thalmann Buy
2022-01-19 개시 B. Riley Securities Buy
2021-12-22 개시 Raymond James Outperform
2021-12-20 개시 SVB Leerink Outperform
2021-12-15 개시 Wedbush Outperform
모두보기

Compass Therapeutics Inc 주식(CMPX)의 최신 뉴스

pulisher
Jun 17, 2025

PD-1 and PD-L1 Inhibitors Competitor Landscape Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | Compass Therapeutics, Aurigene Discovery Tech - The Globe and Mail

Jun 17, 2025
pulisher
Jun 16, 2025

SG Americas Securities LLC Buys 545,767 Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

Jun 16, 2025
pulisher
Jun 16, 2025

Compass Therapeutics, Inc. (NASDAQ:CMPX) Shares Acquired by Bank of America Corp DE - Defense World

Jun 16, 2025
pulisher
Jun 15, 2025

Compass Therapeutics, Inc. (NASDAQ:CMPX) Shares Sold by Millennium Management LLC - Defense World

Jun 15, 2025
pulisher
Jun 13, 2025

Two Sigma Investments LP Sells 48,021 Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

Compass Therapeutics Confirms Directors at Annual Meeting - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

Cholangiocarcinoma Market Booming Worldwide, Estimated to Reach USD 2,334.4 Mn by 2032 | Incyte CorporationSOUTHEAST - SOUTHEAST - NEWS CHANNEL NEBRASKA

Jun 12, 2025
pulisher
Jun 12, 2025

Compass Therapeutics And 2 Other Promising Penny Stocks For Your Watchlist - Yahoo Finance

Jun 12, 2025
pulisher
Jun 11, 2025

Squarepoint Ops LLC Acquires New Holdings in Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

Jun 11, 2025
pulisher
Jun 09, 2025

CMPX to Participate in Virtual Meeting Hosted by Piper Sandler | - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

CMPX to Participate in Virtual Meeting Hosted by Piper Sandler | CMPX Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Two Sigma Advisers LP Cuts Stake in Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

Jun 09, 2025
pulisher
Jun 09, 2025

Transition Metals (CVE:XTM) Shares Up 62.5% – Time to Buy? - Defense World

Jun 09, 2025
pulisher
Jun 09, 2025

Atossa Therapeutics, Inc. (NASDAQ:ATOS) Shares Purchased by Two Sigma Advisers LP - Defense World

Jun 09, 2025
pulisher
Jun 05, 2025

BNP Paribas Financial Markets Makes New $27,000 Investment in Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

ProShare Advisors LLC Has $42,000 Position in Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

Jun 05, 2025
pulisher
May 29, 2025

Northern Trust Corp Sells 43,164 Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

May 29, 2025
pulisher
May 29, 2025

Compass Therapeutics, Inc. (CMPX) Stock Analysis: A Biotech Gem with Over 500% Potential Upside - DirectorsTalk Interviews

May 29, 2025
pulisher
May 28, 2025

Compass Therapeutics to Participate in the Jefferies Global Healthcare Conference - GlobeNewswire

May 28, 2025
pulisher
May 27, 2025

Insider Buying: Thomas Schuetz Acquires Additional Shares of Com - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Compass Therapeutics CEO acquires $21,100 in common stock - Investing.com Australia

May 27, 2025
pulisher
May 27, 2025

Compass Therapeutics CEO acquires $21,100 in common stock By Investing.com - Investing.com India

May 27, 2025
pulisher
May 27, 2025

Compass Therapeutics CEO Acquires 10,000 Shares - TradingView

May 27, 2025
pulisher
May 22, 2025

Compass Therapeutics, Inc. (NASDAQ:CMPX) Receives Average Rating of “Buy” from Brokerages - Defense World

May 22, 2025
pulisher
May 19, 2025

Dimensional Fund Advisors LP Buys New Stake in Babcock & Wilcox Enterprises, Inc. (NYSE:BW) - Defense World

May 19, 2025
pulisher
May 19, 2025

Bell Investment Advisors Inc Buys 79 Shares of Apple Inc. (NASDAQ:AAPL) - Defense World

May 19, 2025
pulisher
May 19, 2025

Dark Forest Capital Management LP Cuts Stock Holdings in NVIDIA Co. (NASDAQ:NVDA) - Defense World

May 19, 2025
pulisher
May 19, 2025

Price T Rowe Associates Inc. MD Increases Holdings in Absci Co. (NASDAQ:ABSI) - Defense World

May 19, 2025
pulisher
May 19, 2025

Compass Therapeutics, Inc. (NASDAQ:CMPX) Shares Bought by Price T Rowe Associates Inc. MD - Defense World

May 19, 2025
pulisher
May 19, 2025

Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Purchased by Price T Rowe Associates Inc. MD - Defense World

May 19, 2025
pulisher
May 19, 2025

Ceera Investments LLC Grows Stock Position in Apple Inc. (NASDAQ:AAPL) - Defense World

May 19, 2025
pulisher
May 19, 2025

Apple Inc. (NASDAQ:AAPL) is Sound View Wealth Advisors Group LLC’s Largest Position - Defense World

May 19, 2025
pulisher
May 19, 2025

Frontier Asset Management LLC Acquires 1,041 Shares of Apple Inc. (NASDAQ:AAPL) - Defense World

May 19, 2025
pulisher
May 19, 2025

Rebalance LLC Grows Stake in Apple Inc. (NASDAQ:AAPL) - Defense World

May 19, 2025
pulisher
May 19, 2025

Ocugen, Inc. (NASDAQ:OCGN) Shares Sold by Price T Rowe Associates Inc. MD - Defense World

May 19, 2025
pulisher
May 16, 2025

Voya Investment Management LLC Sells 5,102 Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

May 16, 2025
pulisher
May 14, 2025

Spotlight On Three Promising Penny Stocks In May 2025 - Yahoo Finance

May 14, 2025
pulisher
May 13, 2025

Perspective Therapeutics, Inc. (NYSE:CATX) Shares Acquired by Wells Fargo & Company MN - Defense World

May 13, 2025
pulisher
May 13, 2025

Wells Fargo & Company MN Acquires 13,038 Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

May 13, 2025
pulisher
May 12, 2025

Compass Therapeutics: A Big Positive Signal For Tovecimig In Biliary Tract Cancers - Seeking Alpha

May 12, 2025
pulisher
May 12, 2025

Guggenheim Cuts Compass Therapeutics (NASDAQ:CMPX) Price Target to $10.00 - Defense World

May 12, 2025
pulisher
May 12, 2025

Barclays PLC Has $279,000 Stock Position in Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

May 12, 2025
pulisher
May 10, 2025

Mariner LLC Purchases New Stake in Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

May 10, 2025
pulisher
May 09, 2025

Guggenheim Adjusts Price Target for Compass Therapeutics (CMPX) - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Compass Therapeutics (CMPX) Price Target Lowered by Guggenheim | CMPX Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Compass Therapeutics Reports 2025 First Quarter Financial Results and Provides Corporate Update - GlobeNewswire

May 09, 2025
pulisher
May 09, 2025

Compass Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 09, 2025
pulisher
May 08, 2025

Compass Therapeutics, Inc. SEC 10-Q Report - TradingView

May 08, 2025
pulisher
May 06, 2025

Compass Therapeutics to Participate in Upcoming May Investor Events - GlobeNewswire

May 06, 2025
pulisher
May 05, 2025

Renaissance Technologies LLC Grows Stock Holdings in Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

May 05, 2025
pulisher
May 05, 2025

Cholangiocarcinoma Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies - Barchart.com

May 05, 2025

Compass Therapeutics Inc (CMPX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Compass Therapeutics Inc 주식 (CMPX) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
GORDON CARL L
Director
Apr 09 '25
Sale
1.59
3,571,428
5,678,571
0
ORBIMED ADVISORS LLC
Director
Apr 09 '25
Sale
1.59
3,571,428
5,678,571
0
$20.42
price down icon 1.37%
$35.45
price up icon 0.65%
$21.06
price down icon 1.92%
$101.83
price down icon 0.41%
$105.86
price down icon 0.39%
biotechnology ONC
$244.00
price down icon 3.69%
자본화:     |  볼륨(24시간):